Global Anti-Coccidial Drugs Market By Type (Synthetic Drugs, Polyether Antibiotics or Ionophores, Combination Anti-Coccidial Drugs, Others), Animals (Swine, Fish, Cattle, Poultry, Others), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa), Industry Trends and Forecast to 2027
Global anti-coccidial drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market.
Growing cases of coccidial infection in animals drives the anti-coccidial drugs market. Due to rising incidence of coccidiosis in food-producing animals and companion animals also boost up the anti-coccidial drugs market growth. However, advancements in veterinary healthcare also drive the market. But, lack of product or drugs awareness and presence of alternative treatment in the may hamper the anti-coccidial drugs market.
Coccidiosis is caused by single-celled parasites (protozoa) called Eimeria, which undergo a simple life cycle in the gut. Any drug used to combat the progression of coccidiosis in birds or animals, both food producing and non-food producing is termed as an anticoccidial.
This anti-coccidial drugs market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief our team will help you create a revenue impact solution to achieve your desired goal.
Global Anti-Coccidial Drugs Market Scope and Market Size
The anti-coccidial drugs market is segmented on the basis of type, animals, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets
On the basis of type, the anti-coccidial drugs market is segmented into synthetic drugs, polyether antibiotics or ionophores, combination anti-coccidial drugs and others. Synthetic drugs are further segmented into robenidine, amprolium, clopidol, decoquinate, diclazuril and others. Polyether antibiotics or ionophores further divided into monovalent ionophores, divalent ionophores and others.
- On the basis of animals, the anti-coccidial drugs market is segmented into swine, fish, cattle, poultry and others.
- On the basis of end-users, the anti-coccidial drugs market is segmented into hospitals, specialty clinics, home healthcare and others.
- On the basis of distribution channel, the anti-coccidial drugs market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others
Anti-Coccidial Drugs Market Country Level Analysis
Anti-coccidial drugs market is analysed and market size information is provided by country, type, animals, end-users and distribution channel as referenced above.
The countries covered in the anti-coccidial drugs market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographically estimation, North America accounts the largest market share due to increased healthcare and R&D expenditure and presence of skilled professionals. Asia-Pacific is expected to account for the largest market share over coming years for the anti-coccidial drugs market due to increased poultry farming and increased awareness for anti-coccidial drugs through advertisement and media and rapidly improving health care infrastructure in the region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Anti-coccidial drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Anti-Coccidial Drugs Market Share Analysis
Anti-coccidial drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to anti-coccidial drugs market.
The major players covered in the anti-coccidial drugs market are Impextraco NV, Vetoquinol SA, Phibro Animal Health Corporation, Huvepharma, Virbac, Bayer Healthcare, Merck Animal Healthcare, Novartis Animal Healthcare, Smartvet Inc., Zoetis., Elanco., Ceva Sante Animale., ProBioGen among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Anti-Coccidial Drugs Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.